| Name | Title | Contact Details |
|---|
Digital Control Systems is a Portland, OR-based company in the Manufacturing sector.
Named for our founder, Gifford-McMahon Cryocoolers have been the foundation of low-temperature technology for more than 50 years. Today, they are the industry choice for liquefying cryogens such as oxygen, nitrogen and hydrogen. Cryomechs superior products operate in more than 50 countries, providing hundreds of customers with custom-built Cryorefrigerators, Helium Management units, Liquid Nitrogen Plants and Cryostats. Cryomech employs the most respected, forward-thinking minds in the industry. They craft solutions that help our customers get things done in aerospace, biotechnology, superconductor, low-temperature physics and many other applications.
Lemons Glass and Mirror Inc is a Greensboro, NC-based company in the Manufacturing sector.
Roper Technologies is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Roper operates businesses that design and develop software (both license and software-as-a-service) and engineered products and solutions for a variety of niche end markets.
Neos Therapeutics is focused on developing, manufacturing and commercializing branded products utilizing our proprietary extended-release drug delivery technology platform, which serves as the basis for our three product candidates being investigated for the treatment of attention deficit hyperactivity disorder (ADHD). Our ADHD product candidates include the following formulations; oral disintegrating tablets (ODT) and liquid suspension. Drug Delivery Platform: Our proprietary extended-release drug delivery platform has enabled us to create new patient- and caregiver-friendly dosage forms of methylphenidate and amphetamine. Formulations: In 2014 alone, 63.1 million prescriptions for medications with ADHD labeling, and principally in extended-release formulations, were written in the United States. The majority of currently available dosage forms for ADHD are tablets and capsules. The two lead Neos Therapeutics product candidates provide a plasma concentration-time profile that is consistent with once daily dosing in an orally disintegrating tablet that disintegrates in the mouth without water. Our goal is to be a leading pharmaceutical company focused on the development, manufacture and commercialization of branded pharmaceutical products that utilize our proprietary extended-release drug delivery technology platform. Neos Therapeutics is a growing, dynamic company that can provide employees with the opportunities and challenges they need to enjoy a rewarding career and make a difference in the lives of others. Our success depends on a motivated team of people collaborating to create quality healthcare products. This requires employees with exceptional leadership skills, flexibility, technical expertise and a commitment to excellence. We offer competitive compensation packages to full-time employees. We seek to attract the right people and provide incentives and career development that can turn employment into opportunity.